Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
BioNano Genomics, Inc. (BNGO) Prices 33.3M Share Common Stock Offering at $6/Each
-
Bionano Genomics Announces Pricing of $200 Million Underwritten Public Offering of Common Stock
-
BioNano Genomics, Inc. (BNGO) to Offer Common Stock
-
Bionano Genomics Announces Proposed Underwritten Public Offering of Common Stock
-
Bionano Genomics Announces Closing of $101.8 Million Underwritten Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
BioNano Genomics, Inc. (BNGO) Prices 29M Share Common Stock Offering at $3.05/sh
-
Bionano Genomics Announces Pricing of $88.5 Million Underwritten Public Offering of Common Stock
-
BioNano Genomics, Inc. (BNGO) to Offer Common Stock
-
Bionano Genomics Announces Proposed Underwritten Public Offering of Common Stock
-
Bionano to Participate in Maxim Group’s Covid-19 Virtual Conference Series: The Role of Cell Therapy and Clarity on Testing
-
BioNano Genomics, Inc. (BNGO) Prices 54.546M Share Common Offering at $0.18/Sh
-
BIONANO GENOMICS ANNOUNCES PRICING OF $18 MILLION UNDERWRITTEN PUBLIC OFFERING
-
BioNano Genomics, Inc. (BNGO) Prices 20.94M Shares at $0.86/Share with Warrants
-
Bionano Genomics Announces Pricing of $18 Million Underwritten Public Offering
-
Bionano Genomics (BNGO) PT Lowered to $7 at Maxim Group
-
UPDATE: Maxim Group Starts Bionano Genomics (BNGO) at Buy

